Abstract:
Endoscopic delivery of Red/NIR light to the Substantia Nigra to treat Parkinson's Disease in order to raise the energy levels in the substantia nigra.
Abstract:
Methods and systems are provided for delivering visible or infrared biostimulatory energy to bone marrow to subjects having or developing Alzheimer's disease. The radiation is delivered to sites remote from the brain at a dose sufficient to cause stimulated mesenchymal stem cells to appear in the brain and degrade β-amyloid. The energy may be coherent light and can be administered transcutaneously, subcutaneously, or via an intramedullary probe.
Abstract:
Provided is a modular multiple laser source system to produce and deliver laser light for laser therapy and/or surgery, the system including a plurality of laser sources of same or different wavelengths, a focusing lens to focus laser light from the plurality of laser sources to a common output, a casing to enclose the laser sources and focusing lens, an output portion provided to the casing to transmit the laser light from one or more of the plurality of laser sources delivered to the common output, and a communication interface provided to the casing to provide electrical communication between components of the system and a controller, wherein the plurality of laser sources are configured to supply the laser light in different wavelengths and/or combinations of wavelengths according to desired medical procedures.
Abstract:
A method for treating a fungal infection in an infected nail is disclosed. An embodiment includes placing an optical delivery system designed to deliver a laser beam with light having strongly water-absorbed wavelengths to the infected nail. The diseased nail is irradiated with the laser beam, and the fluence and a duration of the laser irradiation received by the nail are adjusted such that by laser energy absorption in a surface portion of the nail a superficial heating of the nail and heat diffusion from said heated surface portion into the infected nail bed are achieved. The bottom of the nail plate in this embodiment is heated to a treatment temperature needed to inactivate the infecting organism.
Abstract:
There is provided a therapeutic apparatus for photodynamic therapy that includes a hollow tube inserted into a living body; an unfolding part that is coupled to one end of the tube and is unfolded; a light irradiation part that is disposed in the unfolding part to irradiate light; and an operating part that is coupled to the other end of the tube to unfold the unfolding part, wherein the light irradiation part irradiates light when the unfolding part is unfolded.The therapeutic apparatus for photodynamic therapy according to the present disclosure allows irradiation of light by unfolding tissues of the curved portion in the living body, using an unfolding part capable of being unfolded depending on the user's selection and the light irradiation part coupled to the unfolding part, there is an effect of allowing the use of the photodynamic therapy even in a portion that cannot be conventionally treated using the photodynamic therapy.
Abstract:
A multi-point light-delivering device, comprising a waveguide carrying light along a longitudinal axis and including multiple optical windows, through which the carried light is out-coupled from the waveguide. The waveguide comprises a tapered region along which the optical windows are distributed, wherein each optical window out-couples a specific subset of propagating modes of the carried light to which the optical window is matched.
Abstract:
The invention provides polynucleotides and methods for expressing light-activated proteins in animal cells and altering an action potential of the cells by optical stimulation. The invention also provides animal cells and non-human animals comprising cells expressing the light-activated proteins.
Abstract:
This invention relates to a light field-modulable optical needle assembly including a coherent light source, a light conduction member and a light modulation member. The light conduction member includes a light incident face that is proximate to the coherent light source, a light exiting face that is opposite to the light incident face and distal from the coherent light source, and a surrounding face that peripherally extends from the light incident face to the light exiting face to be connected therebetween. The light modulation member is disposed proximate to one of the light incident face, the light exiting face and the surrounding face of the light conduction member and is formed with a microstructure. The light emitted from the light field-modulable optical needle assembly has a light output power distribution adjustable by the microstructure of the light modulation member.
Abstract:
The present invention provides for eyeglasses used together with contact lenses to deliver light therapy to the wearer. The eyeglass lenses or frames feature an embedded light source in logical and electrical communication with power, sensors, processors, and other components contained within the eyeglasses. The eyeglass lenses or frames project light into complimentary contact lenses which refract, diffract or reflect light into the wearer's eyes.
Abstract:
Products, compositions, systems, and methods for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The methods may be performed in situ in a non-invasive manner by placing a nanoparticle having a metallic shell on at least a fraction of a surface in a vicinity of a target structure in a subject and applying an initiation energy to a subject thus producing an effect on or change to the target structure directly or via a modulation agent. The nanoparticle is configured, upon exposure to a first wavelength λ1, to generate a second wavelength λ2 of radiation having a higher energy than the first wavelength λ1. The methods may further be performed by application of an initiation energy to a subject in situ to activate a pharmaceutical agent directly or via an energy modulation agent, optionally in the presence of one or more plasmonics active agents, thus producing an effect on or change to the target structure. Kits containing products or compositions formulated or configured and systems for use in practicing these methods.